My practice is focused on corporate transactions, healthcare regulations, administrative appeals, and healthcare compliance matters. I represent post-acute care providers (e.g. skilled nursing facilities, assisted living, hospices, home health agencies, rehabilitation providers), physician groups, management service organizations (MSOs), dental service organizations (DSOs), community hospitals, retail medicine providers (e.g. free standing ERs), ancillary providers (e.g. pharmacies, labs, DME), digital health companies, behavioral health, chiropractors, and veterinary practices, private equity groups and investors in the healthcare industry. 

Due to my healthcare practice, I regularly serve as special counsel in conjunction with white collar criminal defense teams in federal cases or investigations involving healthcare fraud and abuse. In these roles, I assist criminal defense attorneys on health care regulatory violations (e.g. Anti-kickback, OIG exclusion issues, etc.), operations, assessment of plea bargains and the sentencing process.

In addition to my healthcare practice, I developed a cannabis regulatory and corporate practice starting in late 2013. I formerly served as outside general counsel for the Texas Cannabis Industry Association, served on the National Cannabis Industry Association’s FDA coalition, which helped co-author a FDA primer in preparation for the 2019 FDA public hearing on CBD products, and currently serve as an advisory board member to a hemp bio-pharmaceutical development company. I represent and regularly advise a broad base of cannabis related clients, including, physicians, private equity groups investing in the cannabis industry, cultivators, processors, wholesalers, retailers, distribution centers, reverse distributors, and ancillary providers (e.g. testing labs, biomass brokerage firms, MLM companies etc.) in regulatory and corporate matters.